Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: Transmission patterns and vaccine control

Epidemiology and Infection

Volumn 131, Issue 1, 2003, Pages 757-770

  Abebe, A ^a   Nokes, D J ^b   Dejene, A ^a   Enquselassie, F ^b,c   Messele, T ^a   Cutts, F T ^d  

^a ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CHILD; CLINICAL RESEARCH; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE CONTROL; DISEASE MARKER; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HERD; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PREVALENCE; RISK FACTOR; SCREENING TEST; SEROEPIDEMIOLOGY; SEX DIFFERENCE; VENOUS BLOOD; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; URBAN POPULATION;

EID: 0042856319     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268803008574     Document Type: Article

References (50)

1. Barin F, Perrin J, Chotard J, et al. Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Progress Med Virol 1981; 27: 148-162.
2. Hyams K, Okoth F, Tukei P, et al. Epidemiology of hepatitis B in Eastern Kenya. J Med Virol 1989; 28: 106-109.
3. Tabor E, Bayley AC, Cairns J, Pelleu L, Gerety RJ. Horizontal transmission of hepatitis B virus among children and adults in five rural villages in Zambia. J Med Virol 1985; 15: 113-120.
4. Miller W, Shao J, Weaver D, Shimokura G, Paul D, Lallinger G. Seroprevalence of viral hepatitis in Tanzanian adults. Trop Med Int Health 1998; 3: 757-763.
5. Feret E, Larouze B, Diop B, Sow M, London WT, Blumberg BS. Epidemiology of hepatitis B virus infection in the rural community of Tip, Senegal. Am J Epidemiol 1987; 125: 140-149.
6. Martinson F, Weigle K, Mushahwar I, Weber D, Royce R, Lemon S. Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol 1996; 48: 278-283.
7. Okoth FA, Kobayashi M, Kaptich DC, et al. Sero-epidemiological study for HBV markers and anti-delta in Kenya. East Afr Med J 1991; 68: 515-523.
8. Kiire CF, African RSG. Hepatitis B infection in sub-Saharan Africa. Vaccine 1990; 8: s107-s112.
9. Tsega E, Mengesha B, Hansson BG, Lindberg J, Nordenfelt E. Hepatitis A, B, and delta infection in Ethiopia: a serological survey with demographic data. Am J Epidemiol 1986; 123: 344-350.
10. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press, 1991.
11. Edmunds WJ, Medley GF, Nokes DJ. The transmission dynamics and control of hepatitis B virus in The Gambia. Stat Med 1996; 15: 2215-2233.
12. Edmunds WJ, Medley GF, Nokes DJ. Vaccination against hepatitis B virus in highly endemic areas: waning vaccine-induced immunity and the need for booster doses. Trans R Soc Trop Med Hyg 1996; 90: 436-440.
13. Williams JR, Nokes DJ, Medley GF, Anderson RM. The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes. Epidemiol Infect 1996; 116: 71-89.
14. Williams JR, Nokes DJ, Anderson RM. Targeted hepatitis B vaccination - a cost effective immunisation strategy for the UK? J Epidemiol Commun Health 1996; 50: 667-673.
15. Wilson JN, Nokes DJ, Carman WF. Predictions of the emergence of vaccine-resistant hepatitis B in The Gambia using a mathematical model. Epidemiol Infect 2000; 124: 295-307.
16. Edmunds WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect 1996; 117: 313-325.
17. Tsega E, Nordenfelt E, Hansson BG, Mengesha B, Lindberg J. Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes. Ethiop Med J 1992; 30: 1-33.
18. Tsega E. Epidemiology, prevention and treatment of viral hepatitis with emphasis on new developments. Ethiop Med J 2000; 38: 131-141.
19. Weiland O. The impact of viral hepatitis on the morbidity and mortality of chronic liver disease and hepatocellular carcinoma in Ethiopia. Ethiop Med J 1992; 30: i-iv.
20. Kefene H, Rapicetta M, Rossi GB, et al. Ethiopian National Hepatitis B Study. J Med Virol 1988; 24: 75-84.
21. Nokes DJ, Enquselassie F, Nigatu W, et al. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull WHO 2001; 79: 588-595.
22. Gebreselassie L. Occurrence of hepatitis B surface antigen and its antibody in Ethiopian blood-donors. Ethiop Med J 1983; 21: 205-208.
23. Rapicetta M, Hailu K, Morace G, et al. Prevalence of HBeAg, anti-HBe serological markers and HBV-DNA in asymptomatic carriers in Ethiopia. Euro J Epidemiol 1989; 5: 481-484.
24. Rahlenbeck SI, Yohannes G, Molla K, Reifen R, Assefa A. Infection with HIV, syphilis and hepatitis B in Ethiopia: a survey in blood donors. Int J STD AIDS 1997; 8: 261-264.
25. Tsega E. Viral hepatitis during pregnancy in Ethiopia. East Afr Med J 1976; 53: 270-277.
26. Tsega E, Hansson B-G, Krawczynski K, Nordenfelt E. Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy. Clinical Infect Dis 1992; 14: 961-965.
27. Tsega E, Mengesha B, Nordenfelt E, Hansson BG, Lindberg J. Prevalence of hepatitis B virus markers among Ethiopian blood donors: is HBsAg screening necessary? Trop Geogr Med 1987; 39: 336-340.
28. Tsega E, Tsega M, Mengesha B, Nordenfelt E, Hansson BG, Lindberg J. Transmission of hepatitis B virus infection in Ethiopia with emphasis on the importance of vertical transmission. Int J Epidemiol 1988; 17: 874-879.
29. Fontanet AL, Messele T, Dejene A, et al. Age- and sex-specific HIV-1 prevalence in the urban community setting of Addis Ababa, Ethiopia. Aids 1998; 12: 315-322.
30. Cutts FT, Abebe A, Messele T, et al. Sero-epidemiology of rubella in the urban population of Addis Ababa, Ethiopia. Epidemiol Infect 2000; 124: 467-479.
31. Population Housing and Census Commission. The 1994 population and housing census of Ethiopia. Results for Addis Ababa Vol. 1 - statistical report. Addis Ababa, Ethiopia: Central Statistical Authority, 1995.
32. Population Housing and Census Commission. The 1984 population census of Ethiopia. Results for Addis Ababa. Addis Ababa: Central Statistical Authority, 1985.
33. Bennett S, Woods T, Liyange WM, Smith DL. A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q 1991; 44: 98-106.
34. Smith P, Morrow R. Field trials of health interventions in developing countries: a toolbox. London: Macmillan Education Ltd, 1996: 362.
35. Nokes DJ, Forsgren M, Gille E, Ljungstrom I. Modelling longitudinal toxoplasma seroprevalence in Stockholm, Sweden. Parasitol 1993; 107: 33-40.
36. McLean AR, Anderson RM. Measles in developing countries, Part I Epidemiological parameters and patterns. Epidemiol Infect 1988; 100: 111-133.
37. McLean AR. Mathematical modelling of the immunisation of populations. Rev Med Virol 1992; 2: 141-152.
38. Enquselassie F, Ayele W, Dejeue A, et al. Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination. Epidemiol Infect. In press.
39. Bowry TR. Seroepidemiology of Hepatitis B in an urban population of Nairobi, Kenya. J Infect Dis 1983; 148: 1122.
40. Triki H, Said N, Ben Salah A, et al. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 1997; 91: 11-14.
41. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000; 18 (Suppl 1): S20-S22.
42. Maynard JE, Kane MA, Hadler SC. Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the expanded programme on immunization. Rev Infect Dis 1989; 2: S574-S579.
43. Colombo M, Gerber MA, Vernace SJ, Gianotti F, Paronetto F. Immune response to hepatitis B virus in children with papular acrodermatitis. Gastroenterol 1977; 73: 1103-1106.
44. Coursaget P, Yvonnet B, Chotard J, et al. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol 1987; 22: 1-5.
45. McMahon BJ, Alward WLM, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603.
46. Kashiwagi S, Hayashi J, Nomura H, Ikematsu H, Kajiyama W. Large-scale survey of hepatitis B virus infection in families. Microbiol Immunol 1985; 29: 951-958.
47. Sobeslavsky O. Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study. Bull WHO 1980; 58: 621-628.
48. Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC. The influence of age on the development of the hepatitis B carrier state. Proc R Soc Lond B Biol Sci 1993; 253: 197-201.
49. Medley GF, Lindop NA, Edmunds WJ, Nokes DJ. Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control. Nat Med 2001; 7: 619-624.
50. Edmunds W, Dejene A, Mekonnen Y, Haile M, Alemnu W, Nokes D. The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa. Health Policy Plan 2000; 15: 408-416.